Metformina farmaco anti-aging? Tra promesse ed evidenze

Il Diabete Pub Date : 2022-07-11 DOI:10.30682/ildia2202d
Vittoria Cataldo, G. Paolisso
{"title":"Metformina farmaco anti-aging? Tra promesse ed evidenze","authors":"Vittoria Cataldo, G. Paolisso","doi":"10.30682/ildia2202d","DOIUrl":null,"url":null,"abstract":"Biological aging results from molecular and cellular damage over time. This process determines a progressive decrease in physical and functional capacity, an increased risk of disease and death. Therefore, the identification of the molecular mechanisms of aging has led to research for senotherapeutic strategies. Metformin is an oral hypo¬glycaemic drug. It is the first choice for the treatment of type 2 dia-betes mellitus (T2DM). However, clinical and preclinical evidence has shown the beneficial effects of metformin also in cardiovascular dis-eases, neurodegenerative diseases, and aging. This editorial explores the recent evidence on metformin as an anti-aging drug.","PeriodicalId":119243,"journal":{"name":"Il Diabete","volume":"62 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Il Diabete","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30682/ildia2202d","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Biological aging results from molecular and cellular damage over time. This process determines a progressive decrease in physical and functional capacity, an increased risk of disease and death. Therefore, the identification of the molecular mechanisms of aging has led to research for senotherapeutic strategies. Metformin is an oral hypo¬glycaemic drug. It is the first choice for the treatment of type 2 dia-betes mellitus (T2DM). However, clinical and preclinical evidence has shown the beneficial effects of metformin also in cardiovascular dis-eases, neurodegenerative diseases, and aging. This editorial explores the recent evidence on metformin as an anti-aging drug.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
甲化抗衰老药物?承诺和证据
随着时间的推移,分子和细胞的损伤导致了生物衰老。这一过程决定了身体和功能能力的逐渐下降,疾病和死亡的风险增加。因此,对衰老的分子机制的识别导致了老年治疗策略的研究。二甲双胍是一种口服降糖药物。是治疗2型糖尿病(T2DM)的首选药物。然而,临床和临床前证据表明,二甲双胍在心血管疾病、神经退行性疾病和衰老方面也有有益的作用。这篇社论探讨了二甲双胍作为抗衰老药物的最新证据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
ALIMENTI E PREVENZIONE DELLE MALATTIE CARDIOVASCOLARI I TRIGLICERIDI COME FATTORE DI RISCHIO CARDIOVASCOLARE LIPODISTROFIE: QUANDO MAGRO NON È SINONIMO DI METABOLICAMENTE SANO MEDICINA RIGENERATIVA E DIABETE DI TIPO 1: I PROGRESSI DELLA BIOINGEGNERIA APPLICATI ALLA SOSTITUZIONE DELLA FUNZIONE BETA-CELLULARE EFFETTI BENEFICI DI UN NUOVO COMPOSTO OMEGA-3
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1